Nisa Investment Advisors
INDV icon

Nisa Investment Advisors’s Indivior Pharmaceuticals INDV Stock Holding History

Nisa Investment Advisors’s Portfolio INDV Stock Details INDV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$90.9K Sell
2,215
-644
-23% -$23.4K ﹤0.01% 1596
2026
Q1 		$87.1K Buy
2,859
+1,570
+122% +$51.9K ﹤0.01% 1478
2025
Q4 		$46.2K Buy
1,289
+224
+21% +$6.84K ﹤0.01% 1642
2025
Q3 		$25.7K Hold
1,065
– – ﹤0.01% 1883
2025
Q2 		$15.7K Buy
+1,065
New +$12.4K ﹤0.01% 2058

Other funds holding INDV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
CAM
Claret Asset Management Montreal, Quebec, Canada $928M AUM 25.4% 1-Year Est. Return

Nisa Investment Advisors's INDV Position: Q2 2026 in Review

Nisa Investment Advisors reduced its Indivior Pharmaceuticals (INDV) stake by 23% in Q2 2026, selling an estimated $23.4K and leaving 2,215 shares worth $90.9K. The position accounts for ﹤0.01% of the portfolio, ranked #1596.

Nisa Investment Advisors first reported a position in INDV in Q2 2025 and has held it in 5 quarters since. 165 funds tracked by Wall St. Rank hold INDV as of Q2 2026.

  • Nisa Investment Advisors held 2,215 shares of Indivior Pharmaceuticals worth $90.9K as of Q2 2026.
  • Nisa Investment Advisors sold 644 Indivior Pharmaceuticals shares in Q2 2026, an estimated $23.4K.
  • Indivior Pharmaceuticals made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q2 2026, its #1596 holding.
  • Nisa Investment Advisors first reported a position in Indivior Pharmaceuticals in Q2 2025 and has held it in 5 quarters since.
  • 165 funds tracked by Wall St. Rank held Indivior Pharmaceuticals as of Q2 2026.

Based on Nisa Investment Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.